CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents, $826 reserved at June 30, 2014	$ 4,193	$ 6,258
Other current assets	345	233
Total current assets	4,538	6,491
Patent license rights, net	745	823
Furniture and equipment, net	0	3
Total assets	5,283	7,317
Current liabilities
Accounts payable	112	88
Other accrued liabilities	318	12
Total current liabilities	430	100
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 100,000,000 shares authorized;40,885,411 shares in 2014 and 2013 issued and outstanding	20	20
Additional paid-in capital	189,264	189,215
Accumulated deficit ($156,669 at June 30, 2014 and $154,256 at December 31, 2013, accumulated during development stage period)	(184,431)	(182,018)
Total Capstone Therapeutics Corp. stockholders' equity	4,853	7,217
Noncontrolling interest	0	0
Total equity	4,853	7,217
Total liabilities and equity	$ 5,283	$ 7,317